Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature
- PMID: 17001034
- PMCID: PMC2242404
- DOI: 10.1110/ps.062324206
Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature
Abstract
p53 modulates a large number of cellular response pathways and is critical for the prevention of cancer. Wild-type p53, as well as tumorigenic mutants, exhibits the singular property of spontaneously losing DNA binding activity at 37 degrees C. To understand the molecular basis for this effect, we examine the folding mechanism of the p53 DNA binding domain (DBD) at elevated temperatures. Folding kinetics do not change appreciably from 5 degrees C to 35 degrees C. DBD therefore folds by the same two-channel mechanism at physiological temperature as it does at 10 degrees C. Unfolding rates, however, accelerate by 10,000-fold. Elevated temperatures thus dramatically increase the frequency of cycling between folded and unfolded states. The results suggest that function is lost because a fraction of molecules become trapped in misfolded conformations with each folding-unfolding cycle. In addition, at 37 degrees C, the equilibrium stabilities of the off-pathway species are predicted to rival that of the native state, particularly in the case of destabilized mutants. We propose that it is the presence of these misfolded species, which can aggregate in vitro and may be degraded in the cell, that leads to p53 inactivation.
Figures







Similar articles
-
Kinetic partitioning during folding of the p53 DNA binding domain.J Mol Biol. 2005 Jul 29;350(5):906-18. doi: 10.1016/j.jmb.2005.05.060. J Mol Biol. 2005. PMID: 15982667
-
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.Biochemistry. 2003 Mar 4;42(8):2396-403. doi: 10.1021/bi026635n. Biochemistry. 2003. PMID: 12600206
-
Zn(2+)-dependent misfolding of the p53 DNA binding domain.Biochemistry. 2007 Mar 13;46(10):2630-9. doi: 10.1021/bi062106y. Epub 2007 Feb 13. Biochemistry. 2007. PMID: 17297920
-
Giant leap for p53, small step for drug design.Bioessays. 1995 Jan;17(1):3-7. doi: 10.1002/bies.950170103. Bioessays. 1995. PMID: 7702591 Review.
-
Reactivation of mutant p53: molecular mechanisms and therapeutic potential.Oncogene. 2007 Apr 2;26(15):2243-54. doi: 10.1038/sj.onc.1210295. Oncogene. 2007. PMID: 17401433 Review.
Cited by
-
Amyloid aggregates induced by the p53-R280T mutation lead to loss of p53 function in nasopharyngeal carcinoma.Cell Death Dis. 2024 Jan 11;15(1):35. doi: 10.1038/s41419-024-06429-8. Cell Death Dis. 2024. PMID: 38212344 Free PMC article.
-
Cryo-LESA Mass Spectrometry-a Step Towards Truly Native Surface Sampling of Proteins.J Am Soc Mass Spectrom. 2019 Jul;30(7):1179-1189. doi: 10.1007/s13361-019-02178-7. Epub 2019 Mar 29. J Am Soc Mass Spectrom. 2019. PMID: 30927181
-
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4. Cancer Commun (Lond). 2024. PMID: 38311377 Free PMC article. Review.
-
Navigating the complexity of p53-DNA binding: implications for cancer therapy.Biophys Rev. 2024 Jul 11;16(4):479-496. doi: 10.1007/s12551-024-01207-4. eCollection 2024 Aug. Biophys Rev. 2024. PMID: 39309126 Free PMC article. Review.
-
Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.J Mol Biol. 2011 Jun 10;409(3):358-68. doi: 10.1016/j.jmb.2011.03.047. Epub 2011 Mar 30. J Mol Biol. 2011. PMID: 21457718 Free PMC article.
References
-
- Alexander, P., Orban, J., and Bryan, P. 1992. Kinetic analysis of folding and unfolding the 56 amino acid IgG-binding domain of streptococcal protein G. Biochemistry 31 7243–7248. - PubMed
-
- Bartek, J., Bartkova, J., Vojtesek, B., Staskova, Z., Lukas, J., Rejthar, A., Kovarik, J., Midgley, C.A., Gannon, J.V., and Lane, D.P. 1991. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6 1699–1703. - PubMed
-
- Bell, S., Klein, C., Muller, L., Hansen, S., and Buchner, J. 2002. p53 contains large unstructured regions in its native state. J. Mol. Biol. 322 917–927. - PubMed
-
- Bullock, A.N., Henckel, J., and Fersht, A.R. 2000. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: Definition of mutant states for rescue in cancer therapy. Oncogene 19 1245–1256. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous